Allucent News and Activities

Headquarters: United States (USA)

Allucent is owned by Neuland.

Neuland is one of the...

Neuland is a company listed under the stock ticker NEULANDLAB (IN).

Neuland has a direct presence in 2 countries.

They are in:

View the org chart displaying its 22 main executives

Brant Nicks has joined the company as Therapeutic Strategy Head, Hematology and Oncology (posted on April 7 2026).
Maria-Cruz Morillo who was Global Operations Head, Global Project Leadership, Rare Diseases, becomes Head of Advanced Therapies, Cell and Gene Therapies & Rare Disease (posted on April 7 2026).
Mila Grieg who was Executive Medical Director, Therapeutic Area Medical Lead Infection Diseases, Vaccine & Allergy, becomes Vice President, Medical Affair, Head of Immunology, Inflammantion and Cardiometabolic (posted on April 7 2026).

Sucheth Rao who was Chief Executive Officer and Vice Chairman, becomes Executive Vice Chairman of the Board (posted on April 3 2026).
Saharsh Davuluri, who was Vice Chairman and Managing Director, is promoted to Chief Executive Officer (posted on April 3 2026).

Create your alert
to follow the executive moves at Allucent.